Personalized Medicine: Molecular Stratification of DCM patients
- Universitätsmedizin Greifswald
- Stephan B. Felix
The discovery of inflammatory processes involved in the development of cardiomyopathies has lead to the development of new therapies. The aim of this project is to use existing patient cohorts with dilated cardiomyopathy to investigate individual inflammatory risk profiles. Biomaterials will be investigated regarding new factors indicating an individual predisposition for developing the disease or factors influencing the progression of the disease. Generated hypotheses shall be further explored in experimental settings e.g. cell cultures or animal models. The major aim is to create new insights into the pathegenesis of DCM and to develop new diagnostic tools for dilated cardiomyopathy which may be also relevant for new therapeutic approaches.
- dilated cardiomyopathy, risk profiles, biomarker, inflammatory processes, animal models, cell culture
- Inflammatory heart diseases
- € 557.524,86